These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 19184369)
1. Lipopolysaccharide upregulates uPA, MMP-2 and MMP-9 via ERK1/2 signaling in H9c2 cardiomyoblast cells. Cheng YC; Chen LM; Chang MH; Chen WK; Tsai FJ; Tsai CH; Lai TY; Kuo WW; Huang CY; Liu CJ Mol Cell Biochem; 2009 May; 325(1-2):15-23. PubMed ID: 19184369 [TBL] [Abstract][Full Text] [Related]
2. ERK1/2 mediates the lipopolysaccharide-induced upregulation of FGF-2, uPA, MMP-2, MMP-9 and cellular migration in cardiac fibroblasts. Chen LC; Shibu MA; Liu CJ; Han CK; Ju DT; Chen PY; Viswanadha VP; Lai CH; Kuo WW; Huang CY Chem Biol Interact; 2019 Jun; 306():62-69. PubMed ID: 30980805 [TBL] [Abstract][Full Text] [Related]
3. Attenuation of the LPS-induced, ERK-mediated upregulation of fibrosis-related factors FGF-2, uPA, MMP-2, and MMP-9 by Carthamus tinctorius L in cardiomyoblasts. Han CK; Tien YC; Jine-Yuan Hsieh D; Ho TJ; Lai CH; Yeh YL; Hsuan Day C; Shen CY; Hsu HH; Lin JY; Huang CY Environ Toxicol; 2017 Mar; 32(3):754-763. PubMed ID: 27098997 [TBL] [Abstract][Full Text] [Related]
4. JNK suppression is essential for 17β-Estradiol inhibits prostaglandin E2-Induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells. Hsu HH; Hu WS; Lin YM; Kuo WW; Chen LM; Chen WK; Hwang JM; Tsai FJ; Liu CJ; Huang CY J Biomed Sci; 2011 Aug; 18(1):61. PubMed ID: 21859479 [TBL] [Abstract][Full Text] [Related]
5. p38α MAPK mediates 17β-estradiol inhibition of MMP-2 and -9 expression and cell migration in human lovo colon cancer cells. Hsu HH; Liu CJ; Shen CY; Chen YJ; Chen LM; Kuo WH; Lin YM; Chen RJ; Tsai CH; Tsai FJ; Huang CY J Cell Physiol; 2012 Nov; 227(11):3648-60. PubMed ID: 22377968 [TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells. Liu CJ; Cheng YC; Lee KW; Hsu HH; Chu CH; Tsai FJ; Tsai CH; Chu CY; Liu JY; Kuo WW; Huang CY Mol Cell Biochem; 2008 Jun; 313(1-2):167-78. PubMed ID: 18398669 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of urokinase-type plasminogen activator and inhibitor and gelatinase expression via 3 mitogen-activated protein kinases and PI3K pathways during the early development of osteoarthritis. Hsieh YS; Yang SF; Lue KH; Chu SC; Li TJ; Lu KH J Rheumatol; 2007 Apr; 34(4):785-93. PubMed ID: 17299841 [TBL] [Abstract][Full Text] [Related]
8. Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: a potential role in connective tissue destruction. Bodet C; Andrian E; Tanabe S; Grenier D J Cell Physiol; 2007 Jul; 212(1):189-94. PubMed ID: 17299802 [TBL] [Abstract][Full Text] [Related]
9. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways. Liu SQ; Huang JA; Qin MB; Su YJ; Lai MY; Jiang HX; Tang GD Int J Colorectal Dis; 2012 Dec; 27(12):1569-78. PubMed ID: 22684547 [TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis-induced cellular hypertrophy and MMP-9 activity via different signaling pathways in H9c2 cardiomyoblast cells. Lee SD; Wu CC; Chang YC; Chang SH; Wu CH; Wu JP; Hwang JM; Kuo WW; Liu JY; Huang CY J Periodontol; 2006 Apr; 77(4):684-91. PubMed ID: 16584351 [TBL] [Abstract][Full Text] [Related]
11. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer. Ahmed N; Pansino F; Baker M; Rice G; Quinn M J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393 [TBL] [Abstract][Full Text] [Related]
12. The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells. Nalbandian A; Djakiew D Clin Exp Metastasis; 2006; 23(2):107-16. PubMed ID: 16912916 [TBL] [Abstract][Full Text] [Related]
13. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471 [TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation. Rangaswami H; Bulbule A; Kundu GC J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285 [TBL] [Abstract][Full Text] [Related]
15. ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells. Cheng YC; Kuo WW; Wu HC; Lai TY; Wu CH; Hwang JM; Wang WH; Tsai FJ; Yang JJ; Huang CY; Chu CH Mol Cell Biochem; 2009 May; 325(1-2):69-77. PubMed ID: 19184368 [TBL] [Abstract][Full Text] [Related]
16. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation. Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324 [TBL] [Abstract][Full Text] [Related]
18. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. Xie Z; Singh M; Singh K J Biol Chem; 2004 Sep; 279(38):39513-9. PubMed ID: 15269222 [TBL] [Abstract][Full Text] [Related]
19. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. Nicholl SM; Roztocil E; Davies MG J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933 [TBL] [Abstract][Full Text] [Related]